DarioHealth Corp. (DRIO)
NASDAQ: DRIO · Real-Time Price · USD
7.18
-0.18 (-2.45%)
Aug 18, 2026, 4:00 PM EDT - Market closed

DarioHealth Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
2122.3627.0420.3527.6620.51
Revenue Growth
-22.65%-17.31%32.86%-26.41%34.82%170.76%
Gross Profit
12.9314.3418.310.3714.018.07
Operating Income
-31.83-36.66-57.02-56.06-56.81-74.47
Net Income
-7-40.31-30.09-54.86-59.96-67.52
Earnings Per Share
-0.95-10.12-12.27-38.67-50.80-81.40
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
13.9626.0228.4636.849.3635.81
Total Debt
32.4131.7530.1929.5428.050.29
Net Cash (Debt)
-18.45-5.73-1.737.2621.3135.52
Net Cash Growth
----65.95%-40.01%26.60%
Net Cash Per Share
-2.50-1.44-0.715.1118.0342.82

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-25.35-25.94-38.56-30.38-47.85-50.41
Capital Expenditures
-0.14-0.14-0.14-0.58-0.44-0.26
Free Cash Flow
-25.48-26.08-38.7-30.96-48.29-50.67
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
61.57%64.11%67.66%50.95%50.67%39.34%
Operating Margin
-151.60%-163.94%-210.85%-275.46%-205.42%-363.06%
Pretax Margin
-167.65%-186.10%-164.94%-291.68%-224.87%-374.05%
Profit Margin
-33.32%-180.28%-111.28%-269.56%-216.80%-329.16%
FCF Margin
-121.35%-116.66%-143.12%-152.14%-174.60%-247.01%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
3.353.441.112.303.9710.48